ViewRay announced that its image-guided radiation therapy (RT) system is being studied at Siteman Cancer Center, part of Barnes-Jewish Hospital and Washington University School of Medicine.
Researchers evaluated ViewRay's system, which combines simultaneous radiotherapy delivery and MRI for the treatment of cancer, in a group of 27 patients with various types of cancer, including lung, head and neck, breast, and prostate. The purpose of the study was to assess the quality of images captured by ViewRay's MRI technology, according to the firm. The researchers are comparing the new images with available radiation oncology imaging techniques.
MR images produced by the system are used to plan treatments, position patients for treatment, and track each patient's position during therapy, ViewRay said. The device received market clearance from the U.S. Food and Drug Administration (FDA) in May.
